Organon (NYSE: OGN) reported Q2 EPS of $1.00, $0.06 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.56 billion.

GUIDANCE:

Organon sees FY2025 revenue of $6.27-6.37 billion, versus the consensus of $6.22 billion.

For earnings history and earnings-related data on Organon (OGN) click here.